These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29185632)

  • 1. [Local treatment in oligometastatic urological malignancies : evidence of wishful thinking ?].
    Valerio M; Cerantola Y; Lucca I; Berthold D; Jichlinski P
    Rev Med Suisse; 2017 Nov; 13(585):2083-2086. PubMed ID: 29185632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining oligometastatic state in uro-oncological cancers.
    Fazekas T; Miszczyk M; Matsukawa A; Nyirády P; Shariat SF; Rajwa P
    Curr Opin Urol; 2024 Jul; 34(4):261-265. PubMed ID: 38704827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oligometastatic and locally advanced urological tumors : State-of-the-art diagnostic workup prior to individualized, multimodal therapy].
    Thomas C; Hadaschik B
    Urologe A; 2021 Dec; 60(12):1525-1526. PubMed ID: 34714370
    [No Abstract]   [Full Text] [Related]  

  • 4. [Supportive care for urological metastatic patients].
    Lebret T; Di Palma M; Ripoll J; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S410-4. PubMed ID: 19070824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy indications in the treatment of metastases from urological malignancies].
    Nguyen TD; Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S223-7. PubMed ID: 19070796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis-directed therapy among urological malignancies: where do we stand?
    Re C; Stewart GD; Capitanio U
    Curr Opin Urol; 2024 Jul; 34(4):258-260. PubMed ID: 38835186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Eight-MHZ RF hyperthermia in urological malignancies].
    Hisazumi H; Nakajima K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1382-6. PubMed ID: 3382206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric urological cancer.
    Hohenfellner R; Gutjahr P
    World J Urol; 1995; 13(4):201-2. PubMed ID: 8528291
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
    Kim J; Park JS; Ham WS
    Investig Clin Urol; 2017 Sep; 58(5):307-316. PubMed ID: 28868501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy indications in the treatment of metastases from urological malignancies].
    Théodore C
    Prog Urol; 2008 Nov; 18 Suppl 7():S219-22. PubMed ID: 19070795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review.
    Koo KC; Dasgupta P
    Yonsei Med J; 2018 Jul; 59(5):567-579. PubMed ID: 29869454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
    Bamias A
    Eur Urol; 2007 Oct; 52(4):1113-4. PubMed ID: 17367916
    [No Abstract]   [Full Text] [Related]  

  • 13. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
    Boissier R; Hevia V; Bruins HM; Budde K; Figueiredo A; Lledó-García E; Olsburgh J; Regele H; Taylor CF; Zakri RH; Yuan CY; Breda A
    Eur Urol; 2018 Jan; 73(1):94-108. PubMed ID: 28803033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of the pathologist in the diagnosis of metastases from urological malignancies].
    Molinié V
    Prog Urol; 2008 Nov; 18 Suppl 7():S178-95. PubMed ID: 19070790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complementary and alternative medicine in urologic oncology].
    Otto T; Suhr J; Rübben H
    Urologe A; 2003 Nov; 42(11):1461-5. PubMed ID: 14624344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with radiotherapy in urological malignancies.
    Mehta S; Illidge T; Choudhury A
    Curr Opin Urol; 2016 Nov; 26(6):514-22. PubMed ID: 27552139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PET-FDG in metastases from urological malignancies].
    Labarthe P; Méjean A; Lebret T
    Prog Urol; 2008 Nov; 18 Suppl 7():S208-12. PubMed ID: 19070793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined treatment of radiofrequency hyperthermia and irradiation in advanced urological malignancies].
    Nakajima K; Hisazumi H; Naito K; Misaki T; Saito Y; Takashima T
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2286-90. PubMed ID: 3831173
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary prevention after urological cancers. What are the pertinent facts about aftercare?].
    Schroeder A
    Urologe A; 2007 Jun; 46(6):642-5. PubMed ID: 17447048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.